RME Hot Seat: Immunotherapy for Multiple Myeloma
Jointly provided by
Support for this activity has been provided through educational grants from Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics, Inc; and Sanofi Genzyme.
Release date: 1/4/2021
Expiration date: 1/4/2022
Estimated time to complete: 0.5 hour
The number and type of treatments for multiple myeloma continue to expand rapidly. The emergence of several new immunotherapy options holds particular promise for patients with relapsed/refractory myeloma, but effectively integrating these approaches into practice remains a significant challenge.
Developed for oncology nurses and advanced practitioners, this RME Hot Seat provides a virtual Q&A with a panel of experts who field a range of questions on the use of antibody-based therapies, bispecific T-cell engagers, chimeric antigen receptor T–cell therapy, and other new and emerging immunotherapeutic options for myeloma patient care.
Colleen Harker Erb, MSN, CRNP, ACNP-BC, AOCNP
Abramson Cancer Center – Penn Medicine
Angela M. Vickroy, ANP-BC, OCN
Washington University School of Medicine
St. Louis, Missouri
This activity has been designed to meet the educational needs oncology nurses, advanced oncology certified nurse practitioners, and other health care providers involved in the care of oncology patients.
At the conclusion of this activity, participants should be better able to:
- Distinguish between mechanisms of action and safety profiles of multiple myeloma immunotherapies
- Evaluate recent clinical advances in the use of existing and emerging immunotherapies and their potential implications for clinical practice
Purdue University Continuing Nursing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is approved for 0.5 Nursing Contact Hour
According to the disclosure policy of the Purdue University Continuing Nursing Education, all faculty, planning committee members, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosures are as follows:
Colleen Harker Erb, MSN, CRNP, ACNP-BC, AOCNP, has disclosed no relevant financial relationships.
Angela M. Vickroy, ANP-BC, OCN, has disclosed no relevant financial relationships.
Purdue University Continuing Nursing Education
Faculty and staff involved in the development and review of this activity have disclosed no relevant financial relationships.
Multiple Myeloma Research Foundation
Mary DeRome, Director of Medical Communications and Education, has disclosed no relevant financial relationships.
Denise C. LaTemple, PhD, Director of Scientific Services, has disclosed no relevant financial relationships.
Yvette Murley, PhD, Medical Director, has disclosed no relevant financial relationships.
Kristen Petro Slade, Director of Operations, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.
Karen Smith, Creative Director, has disclosed no relevant financial relationships.
Karen Tenaglia, Project Manager, has disclosed no relevant financial relationships.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Purdue University Continuing Nursing Education; RedMedEd; the Multiple Myeloma Research Foundation; Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics, Inc.; and Sanofi Genzyme do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Purdue University Continuing Nursing Education; RedMedEd; the Multiple Myeloma Research Foundation; Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics, Inc.; or Sanofi Genzyme. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Method of Participation
There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive CNE credit for participation, participants must complete the posttest (achieving a passing grade of 75% or greater) and program evaluation. Certificates can be printed immediately.
- Apple iPad, iPad mini (iOS 11 or higher), iPhones (iOS 11 or higher), and Android Phones (4.0.3 or higher) with an Internet connection
- Internet browsers: Chrome, Firefox, Safari
- A computer with an Internet connection
- Internet browsers (PC): Chrome, Firefox, Microsoft Edge, and Internet Explorer 11 or higher.
- Internet browsers (Mac): Chrome, Firefox, and Safari 13 or higher
CNE credit for this activity is provided by Purdue University. If you register for CNE credit for this educational activity, RedMedEd will forward relevant personally identifiable information to Purdue University so that records can be maintained concerning any credits issued to you. Aggregated data concerning registrations, posttests, and evaluations may be shared, but RedMedEd will not knowingly share any personally identifiable information. The information you provide on this site may be used to contact you about your credit or other relevant educational activities provided through Purdue or RedMedEd. For more information, contact Purdue University at Pharmacy-CECR@purdue.edu or RedMedEd at firstname.lastname@example.org.
© 2020. This CNE-certified program is held as copyrighted by Purdue University, MMRF, and RedMedEd. Through this notice, Purdue University, MMRF, and RedMedEd grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owners.